Effect of diazepam on adenosine 3′,5′-cyclic monophosphate (cAMP) plasma levels in anesthetized patients
Authors:
- 31 May 2004
- journal article
- clinical trial
- Published by Elsevier in Clinical Therapeutics
- Vol. 26 (5) , 737-743
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Reevaluating the role of phosphodiesterase inhibitors in the treatment of cardiovascular diseaseClinical Cardiology, 2002
- Diazepam potentiates the effects of endogenous catecholamines on contractility and cyclic AMP levels in rat ventricular myocardiumNaunyn-Schmiedeberg's Archives of Pharmacology, 2002
- Synergistic interaction of diazepam with 3′,5′-cyclic adenosine monophosphate-elevating agents on rat aortic ringsEuropean Journal of Pharmacology, 2001
- Diazepam increases the hypothalamic‐pituitary‐adrenocortical (HPA) axis activity by a cyclic AMP‐dependent mechanismBritish Journal of Pharmacology, 2001
- Diazepam and rolipram differentially inhibit cyclic AMP-specific phosphodiesterases PDE4A1 and PDE4B3 in the mouseBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 2001
- Adaptation in cyclic AMP signalling processes: A central role for cyclic AMP phosphodiesterasesSeminars in Cell & Developmental Biology, 1998
- Functional and biochemical evidence for diazepam as a cyclic nucleotide phosphodiesterase type 4 inhibitorBritish Journal of Pharmacology, 1998
- Cyclic nucleotide phosphodiesterases: functional implications of multiple isoformsPhysiological Reviews, 1995
- The effect of diazepam on adenosine uptake and adenosine-stimuiated adenylate cyclase in guinea-pig brainCanadian Journal of Physiology and Pharmacology, 1982
- Cyclic AMP, adrenaline and noradrenaline in plasma during surgeryBritish Journal of Surgery, 1978